Abstract:Background Down syndrome (DS), a common chromosomal anomaly caused by trisomy of chromosome 21, is characterized by a broad spectrum of phenotypic characteristics across multiple organ systems, including cardiac defects and leukemia. Dermatological findings are prevalent among individuals with DS; however, these issues are frequently underrecognized and inadequately researched, resulting in a significant gap in the provision of comprehensive healthcare strategies. Given the increased life expectancy of patients with DS and delayed manifestation of many dermatoses, physicians are increasingly encountering dermatological findings in this population. Objective This study aimed to assess the prevalence and types of dermatological findings in individuals with DS, compare them with those in a control group, and emphasize the necessity of incorporating dermatological evaluations into routine health monitoring. Methods This prospective cross‐sectional study was conducted from June 2023 to June 2024 and involved 100 genetically confirmed individuals with DS and 100 age‐ and sex‐matched controls. Comprehensive demographic, clinical, and karyotype data were collected for the DS group, and all the participants underwent detailed morphological evaluations. Results The DS group had a mean age of approximately 6.37 years, whereas the controls were around 7 years old, with no significant differences in age or sex distribution between the groups. Karyotype analysis showed that trisomy 21 was present in 92% of the cases, mosaicism in 6%, and translocation in 2%. Common dermatological findings in the DS group included xerosis cutis (49%), thin and sparse hair (48%), dental caries (34%), delayed tooth eruption (28%), nail dystrophy (25%), fissured tongue (23%), and cheilitis (18%). Significant differences were noted in the prevalence of scabies, bacterial infections, and café au lait macules between the DS and control groups (p < 0.01). Dysmorphic findings in the DS group included epicanthal folds (97%), upslanted palpebral fissures (97%), brachycephaly (91%), and single transverse palmar crease (89%). Significant gender differences were noted in the prevalence of brachycephaly and the sandal gap (p < 0.01). Conclusions This study highlights the importance of regular dermatological care in enhancing the health management and quality of life of individuals with DS due to the prevalence and variability of dermatological conditions.

COVID‐19 in patients with Down syndrome: A systematic review

COVID-19 in patients with Down syndrome: Characteristics of hospitalisation and disease progression compared to patients without Down syndrome

Enhancing understanding of SARS-CoV-2 infection among individuals with Down syndrome: An integrative review

Susceptibility to COVID-19 Diagnosis in People with Down Syndrome Compared to the General Population: Matched-Cohort Study Using Primary Care Electronic Records in the UK

COVID‐19 infection in children, adolescents, and young adults with Down syndrome and hematologic malignancies

COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study Of 8 Million Adults

Dysregulation of the Immune System in a Natural History Study of 1299 Individuals with Down Syndrome

What people with Down Syndrome can teach us about cardiopulmonary disease

Immune Dysregulation in Children With Down Syndrome

The Impact of the COVID-19 Pandemic on Individuals with Down Syndrome: A Croatian Survey

Down Syndrome in Children: A Primary Immunodeficiency with Immune Dysregulation

Comprehensive Assessment of Dermatologic and Dysmorphic Manifestations in Patients With Down Syndrome

SARS-CoV-2 Infection Causes Heightened Disease Severity and Mortality in a Mouse Model of Down Syndrome

Sex differences in cardiovascular disease and dysregulation in Down syndrome

Neuropathological findings in Down syndrome, Alzheimer's disease and control patients with and without SARS-COV-2: preliminary findings

Aberrations in Circulating Inflammatory Cytokine Levels in Patients with Down Syndrome: a Meta-Analysis

Efficacy of periodontal treatment modalities in Down syndrome patients: a systematic review and meta-analysis

A systematic review and meta‐analysis of serum lipid concentrations in people with Down syndrome

Views on the impact of the COVID-19 pandemic on health in people with Down syndrome from diverse backgrounds

Recurrent Respiratory Infections in Children with Down Syndrome: A Review

Early death and causes of death of people with Down syndrome: A systematic review